Second-Line T-DXd Data Remain Strong in HER2+ Metastatic Breast Cancer
Trastuzumab deruxtecan improved responses and survival vs T-DM1 in HER2+ metastatic breast cancer after prior exposure to trastuzumab and a taxane.
Source: onclive.com
Burst Edition News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Burst Edition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Burst Edition Today - Breaking & Trending Today
Nadofaragene Firadenovec Showcases Sustained Responses in BCG-Unresponsive NMIBC
The intravesical gene therapy elicited durable remissions in a high percentage of patients with high-risk, BCG-unresponsive non–muscle invasive bladder cancer.
Source: onclive.com
Lonial Spotlights CAR T-Cell and Off-the-Shelf Treatments in Multiple Myeloma
Sagar Lonial, MD, FACP, details how CAR T-cell therapies and off-the-shelf treatments are improving outcomes for patients with multiple myeloma.
Source: onclive.com